Abstract
SummaryAn in vitro assay that measures the ability of mouse spleen cells to inhibit DNA synthesis (IDS) of syngeneic melanoma tumor cells was used in the evaluation of tumor immunity. The IDS assay was used in the measurement of both specific immunity mediated by spleen cells from tumor-bearing mice and nonspecific tumor cell growth inhibition mediated by normal spleen cells. Specific IDS was first demonstrable 2 weeks after injection of 106 B-16 tumor cells sub-cutaneously and persisted during advanced stages of disease. Changes in spleen cell IDS activity were correlated with changing mitogen reactivity during the course of tumor growth. A portion of the spleen cells mediating nonspecific IDS was removed by nylon wool filtration, but the effector cells exhibiting specific immunity were not removed by this procedure. Immune spleen cells did not need to synthesize DNA or divide to inhibit tumor cell DNA synthesis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.